An engineer and an entrepreneur, Steve Verschoor has led polysilicon supplier GTSP Global since 2006. Steve Verschoor has also served in several clinical trials of skin cancer treatments. In 2014, he enrolled in his first clinical trial after he was diagnosed with stage 3 melanoma. He entered a second melanoma clinical trial in 2019.
Melanoma is an aggressive form of skin cancer caused by damaged melanocyte cells. While anyone can develop melanoma, certain factors may increase susceptibility, including skin tone, family history of skin cancer, and sun exposure.
To ensure that melanoma is diagnosed at an early stage, people with high-risk factors should perform monthly self-exams using the ABCDE (asymmetry, irregular borders, color, diameter, and evolution) criteria to monitor suspicious moles. Most dermatologists also recommended annual skin exams. During this exam, the doctor may use a dermatoscope to analyze the skin and take photos to document mole changes. Moles that exhibit signs of melanoma, including scaliness or irregular borders, may be further evaluated through a biopsy.
Steve Verschoor 